Neuphoria Therapeutics reported asset growth of 13.34% for the quarter ended Mar 2026. These growth metrics cover 14 quarters of results from Jun 2021 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Jun2021 | Jun2022 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth Ratios | ||||||||||||||
| Assets Growth (1y) | 5,737.39% | 11.95% | -38.56% | -3.80% | 3.40% | 19.32% | 101.44% | 13.34% | ||||||
| Assets Growth (3y) | 242.43% | -12.86% | -15.14% | |||||||||||
| Assets Growth (5y) | 109.06% | |||||||||||||
| Assets (QoQ) | -17.11% | -20.72% | 69.05% | -6.91% | -4.36% | 33.84% | -4.89% | |||||||
| Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) | 631.45% | 9.55% | -49.26% | 3.36% | -0.65% | -57.22% | 102.29% | 12.71% | 68.88% | 410.98% | 14.06% | |||
| Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y) | 59.60% | -16.87% | -16.08% | |||||||||||
| Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y) | 36.49% | |||||||||||||
| Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) | -33.31% | 24.83% | -17.03% | 49.63% | -35.90% | -46.25% | 292.32% | -16.63% | -3.95% | 62.64% | -12.43% | |||
| Cash from Operations Growth (1y)Cash from Ops. Growth (1y) | -0.07% | 14.88% | 447.59% | -18.32% | 14.28% | -91.49% | -129.42% | |||||||
| Cash from Operations (QoQ)Cash from Ops. (QoQ) | 10.94% | 16.48% | 8.63% | -47.24% | 24.25% | 441.07% | -131.10% | -6.67% | -69.22% | 47.60% | ||||
| EBITDA Margin (QoQ) | 0.06M | 4.39M | ||||||||||||
| EBIT Growth (1y) | 34.75% | 18.66% | 600.29% | -6.52% | -58.44% | -9.65% | -110.12% | |||||||
| EBIT Margin (QoQ) | 0.06M | 4.39M | ||||||||||||
| EBIT (QoQ) | 16.73% | 47.42% | -128.81% | 34.87% | -3.81% | 423.40% | -148.72% | 3.13% | 28.16% | 70.16% | ||||
| EBT Growth (1y) | 82.99% | 57.91% | 504.85% | -466.81% | -961.00% | 194.70% | -104.83% | |||||||
| EBT Margin (QoQ) | 0.04M | 11.62M | ||||||||||||
| EBT (QoQ) | 16.67% | 39.82% | 1.47% | 65.57% | -106.17% | 678.80% | -237.95% | 35.55% | 118.40% | -129.51% | ||||
| EPS (Basic) Growth (1y) | 85.29% | 57.33% | 505.38% | -1,452.68% | -1,130.95% | 195.92% | -104.48% | |||||||
| EPS (Basic) (QoQ) | 16.78% | 39.00% | 140.33% | -171.82% | -141.47% | 679.52% | -234.58% | 34.64% | 118.82% | -127.09% | ||||
| EPS (Diluted) Growth (1y) | 85.29% | 57.33% | 505.38% | -1,452.68% | -1,130.95% | 195.92% | -104.48% | |||||||
| EPS (Diluted) (QoQ) | 16.78% | 39.00% | 140.33% | -171.82% | -141.47% | 679.52% | -234.58% | 34.64% | 118.82% | -127.09% | ||||
| FCF Margin (QoQ) | 0.06M | 2.68M | ||||||||||||
| Free Cash Flow Growth (1y)FCF Growth (1y) | -0.07% | 14.88% | 447.59% | -18.32% | 14.28% | -91.49% | -129.42% | |||||||
| Free Cash Flow (QoQ)FCF (QoQ) | 10.94% | 16.48% | 8.63% | -47.24% | 24.25% | 441.07% | -131.10% | -6.67% | -69.22% | 47.60% | ||||
| Net Cash Flow Growth (1y)NCF Growth (1y) | -22.09% | -306.38% | 915.67% | -169.52% | 88.28% | 337.25% | -126.71% | |||||||
| Net Cash Flow (QoQ)NCF (QoQ) | 144.04% | -192.00% | 365.78% | -213.37% | 25.55% | 463.61% | -122.65% | 80.88% | 1,606.59% | -140.93% | ||||
| Net Income Growth (1y) | 85.29% | 57.33% | 505.38% | -1,452.68% | -1,130.95% | 195.92% | -104.48% | |||||||
| Net Income (QoQ) | 16.78% | 39.00% | 140.33% | -171.82% | -141.47% | 679.52% | -234.58% | 34.64% | 118.82% | -127.09% | ||||
| Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) | 85.29% | 57.33% | 505.38% | -1,452.68% | -1,130.95% | 195.92% | -104.48% | |||||||
| Net Income towards Common Stockholders (QoQ)Net Income (QoQ) | 16.78% | 39.00% | 140.33% | -171.82% | -141.47% | 679.52% | -234.58% | 34.64% | 118.82% | -127.09% | ||||
| Net Margin (QoQ) | 0.04M | 11.42M | ||||||||||||
| Operating Income Growth (1y)Op. Inc Growth (1y) | 34.75% | 18.66% | 600.29% | -6.52% | -58.44% | -9.65% | -110.12% | |||||||
| Operating Income (QoQ)Op. Inc (QoQ) | 16.73% | 47.42% | -128.81% | 34.87% | -3.81% | 423.40% | -148.72% | 3.13% | 28.16% | 70.16% | ||||
| Operating Margin (QoQ) | 0.06M | 4.39M | ||||||||||||
| Profit After Tax Growth (1y)PAT Growth (1y) | 85.29% | 57.33% | 438.31% | -253.66% | -1,130.95% | 195.92% | -104.47% | |||||||
| Profit After Tax (QoQ)PAT (QoQ) | 16.78% | 26.66% | 24.54% | 68.07% | -141.47% | 681.47% | -178.89% | -11.13% | 118.82% | -127.09% | ||||
| Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y) | 1,266.14% | -6.33% | -9.04% | -99.99% | 38.97% | 31.01% | ||||||||
| Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y) | 126.63% | -95.19% | -94.52% | |||||||||||
| Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y) | -70.84% | |||||||||||||
| Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ) | -1.50% | -14.31% | -3.57% | 70.73% | -7.15% | |||||||||
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | -0.00M | -0.00M | -0.01M | |||||||||||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | 631.00 | 0.01M | -0.01M | -0.00M | 0.00M | -0.00M | ||||||||
| Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) | 0.01M | 0.01M | -0.00M | |||||||||||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | -0.00M | 0.01M | -107.00 | -963.00 | 192.00 | -0.00M | ||||||||
| Return on Sales [ROS] (QoQ)ROS (QoQ) | 0.06M | 4.39M | ||||||||||||
| Revenue (QoQ) | 2,163.42% | -100.09% | ||||||||||||
| Share-based Compensation Growth (1y)Stock Comp. Growth (1y) | 38.35% | -99.86% | 69,273.95% | -93.19% | 27.04% | 24.86% | -99.86% | 168.95% | 489.92% | |||||
| Share-based Compensation Growth (3y)Stock Comp. Growth (3y) | -86.66% | |||||||||||||
| Share-based Compensation (QoQ)Stock Comp. (QoQ) | -99.82% | 431.82% | -94.64% | 169.08% | 90,354.83% | -99.95% | 0.00% | 164.47% | 1.88% | -0.19% | 119.35% | |||
| Tax Rate Growth (1y) | 0.00M | -136.00 | -13.00 | -0.01M | -0.00M | -130.00 | 717.00 | |||||||
| Tax Rate (QoQ) | 13.00 | -135.00 | 0.01M | -0.01M | -0.00M | -13.00 | 245.00 | -138.00 | -225.00 | 835.00 |